Clinical studies may be considered for co-enrollment into BOOST-3 as long as there is approval from the study leadership for both studies ahead of time.
Sites should consider any potential logistical concerns before a decision is made to allow for co-enrollment and should be reviewed with local Site PIs. The decision to allow co-enrollment depends on the ability to preserve the scientific integrity of both studies.
Spreading Depolarizations II
DO NOT Co-Enroll: